Clinical Trial for Hidradenitis Suppurativa (21 Weeks)

Adults aged 18-70 with hidradenitis suppurativa (HS) for at least 1 year,may qualify to partcipate. Individuals must have HS lesions present in at least 2 distinct body areas, and a total abscess and inflammatory nodule (AN) count of 5 or more. In addition, qualified participants must not have a history of active skin disease other than HS that could interfere with the assessment of HS.

Participants will receive investigational oral medication (active study drug) or placebo. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses maybe provided.

Total study duration lasts about 21 weeks and involves about 9 visits to the study centre.
 
Call the study centre near you, or register now.
Learn more about
Hidradenitis Suppurativa
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CA

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more